Ali Keshavarzian MD Rush University Medical Center, Chicago, IL

Similar documents
Socioeconomic State & Intestinal Microbiota. Ali Keshavarzian, MD Rush University Medical Center Chicago, IL

HOW THE MICROBIOME AFFECTS OUR HEALTH

Gut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI

Microbiome GI Disorders

Faecalibacterium prausnitzii

The enteric microbiota: Implications for IBD. Eugene B. Chang, M.D. University of Chicago

Exosomes as a. Novel Therapeutic Approach to Gastrointestinal Diseases Rebecca Murray APRN, FNP, CDE

Microbiome in You: Optimizing Gut Bacteria for Better IBD Management

What Have We Learned About the Microbiome in Pediatric IBD?

Dysbiosis & Inflammation

GROUP 5. Jerrold R. Turner Nathalie Delzenne Wenke Feng Reuben Wong Thierry Piche Yehuda Ringel Irina Kirpich Brant Johnson

Slide 1. Slide 2 Learning outcomes. Slide 3. Year 1 MBChB Lecture 15 Introduction to the Gut Microbiota. The importance of microbiota

AUTOIMMUNITY AND THE GUT

4/16/2018. Go with your gut: the gutjoint. Learning objectives: Disclosure of Conflicts of Interest. Collaboration: OpenBiome

THE ROLE OF MICROBIOME IN IBD

Research Update: Looking for the Answers

Is there an anti-inflammatory diet in IBD?

Issues at Hand. Inflammatory Bowel Disease Paradigm. Diet changes the fecal microbiome. Experience with diet in IBD

Pathophysiologic Basis of Autoimmune Disorders

Role of the Gut Microbiota in Autoimmunity

Innate immune regulation of T-helper (Th) cell homeostasis in the intestine

Inflammatory Bowel Diseases (IBD) Clinical aspects Nitsan Maharshak M.D., IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Soura

Slide 1 EXERCISE AND SLEEP. Slide 2 Sleep and Exercise. Slide 3 Stages of Sleep

Functional Nutrition Approaches to Gut Health 20 CPEU Module accredited by Nutrition Mission

Pro and Cons of Intermittent Fasting

Slide 1 MORE ABOUT ZONULIN. Slide 2 Zonulin For Testing Leaky Gut. Slide 3 Zonulin

Abstract. Integrated Immunology Clinic Articles ã

Efficacy and Safety of Treatment for Pediatric IBD

2/5/2015. Sensitive: Discriminative: Simple Inexpensive. Example of a good biomarker: blood tests, CSF test but they are not discriminative for PD

Bibliografia Microbiota

PEDIATRIC INFLAMMATORY BOWEL DISEASE

Genetic and Environmental Risks for IBD

Understanding clinical aspects of Crohn s disease and ulcerative colitis: Implications for the basic scientist

The role of gut microbiome in IBS

There is no single IBD diet

STRESS AND THE HEALTH OF THE BODY

Research in IBD at University of Colorado Denver

MICROBIOMA E IMMUNITA LORENZO EMMI

Efficacy and Safety of Treatment for Pediatric IBD

Intestinal Microbiota in Health and Disease

Gut Microbiome Essentials

Clinically proven to quickly relieve symptoms of common gastrointestinal disorders. TERRAGASTRO - Good health starts in the gut

Gut Lung Axis Implication of the Gut Microbiota beyond its niche

Fecal Microbiota Transplantation for Severe sepsis and Diarrhea : a Case Report

Microbiome, Inflammation and Cancer

Bringing Synbiotic Interventions in Cancer to Practice: from bench to bedside The UC Davis Foods for Health Institute

DISCUSSION GROUP #5 ISAPP 2014 THE MICROBIOME AND HEALTH: PROMISING ENDPOINTS FOR INTERVENTIONS. Friday, June 20, 2014

Beyond the Scope: The Microbiome & The Future of Gastroenterology

New and Emerging Therapies in IBD. Sarah Streett MD, AGAF Clinical Associate Professor of Medicine Stanford University

Beyond the Scope: An Integrative Gastroenterologist s Approach to Digestive Disorders

Dietary Options for Inflammatory Bowel Disease

Update in Pediatric IBD: 2018

Formulations and Availability 900 BILLION 5,319 HIGH POTENCY PROBIOTIC PEDIATRIC ADULT GERIATRIC PROVEN BY RESEARCH. HIGH-POTENCY. NO SHORTCUTS.

Genetics. Environment. You Are Only 10% Human. Pathogenesis of IBD. Advances in the Pathogenesis of IBD: Genetics Leads to Function IBD

New Insights on the Structure of the Human Gut Microbiota. Chaysavanh Manichanh, PhD Vall d Hebron Research Institute Barcelona

The Role of Nutrition, Gut Microbiome, and Gut Permeability in Immunomodulation: The Celiac Disease and Type 1 Diabetes Paradigms

Therapeutic Manipulation of the Gut Microbiota in Patients with IBD

What is the evidence that dietary components can act on the microbiome and influence health?

The Gut Microbiota: Evidence For Gut Microbes as Contributors to Weight Gain

BUTYRATE PRODUCING BACTERIA AS PROBIOTIC TREATMENT IN IBD

IL-12 family members in experimental colitis. Markus F. Neurath I. Medical Clinic Johannes Gutenberg-University Mainz, Germany

Sarkis K Mazmanian, California Institute of Technology

Nature Immunology: doi: /ni Supplementary Figure 1

Medical Therapy for Pediatric IBD: Efficacy and Safety

Mucosal Healing in Crohn s Disease. Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium

The A, B, C s of Bowel Flora

Association of sleep quality and mucosal healing in patients with inflammatory bowel disease in clinical remission

Gut Health Influences and Their Relationship to Cancer Diagnosis

Crohn s Disease. Naturopathic Treatment Options

SIMPOSIO Il microbiota intestinale e la sua modulazione nelle patologie dell asse intestino cervello. Microbiota e IBS.

Inflammation. Yoga for Chronic Pain

Accepted Manuscript. Innate immune cells regulate oncoimmunity and cancer development. Ai-Ping Bai, Yuan Guo

CROHN S DISEASE AND ULCERATIVE COLITIS

Our microbiome: The role of vital gut bacteria, diet, nutrition and obesity

Let s get clear about what a Diarrhea Flare is

Probiotics in the ICU. Who could benefit? Nadia J van Rensburg RD(SA) Groote Schuur Hospital, Cape Town

fever a persistent unexplained change in bowel habit in somebody over 50 years of age a family history of bowel or ovarian cancer.

Genetics of Pediatric Inflammatory Bowel Disease

Position of Biologics in IBD Circa 2006: Top Down vs. Step Up Therapy

Alexander Shikhman MD, PhD Institute for Specialized Medicine July 20, 2013

New perspectives on the link between nutrition and the immune system. Jurriaan Mes Wageningen UR - Food & Biobased Research

Microbiome analysis: from concept to completion. Matthew Stoll MD,PhD,MSCS January 26, 2015

4/17/2019 DISCLOSURES OBJECTIVES GI MICROBIOME & HEALTH: A REVIEW. Nancy C. Kois, MD, FCAP Contemporary Pathology Services. There are no disclosures

The Role of Food in the Functional Gastrointestinal Disorders

Personalized Medicine. Selecting the Right First-line Biologic Agent. Gene Expression Profiles Crohn s Disease. The Right Treatment

Disclosures. Outline. Nothing to disclose. Dysbiosis and the gut barrier. Endotoxemia and the liver. Impact of products of bacterial metabolism

VITAMINS, MINERALS AND THE GUT

Panel 1: Risk of Performance Decrements and Adverse Health Outcomes Resulting from Sleep Loss, Circadian Desynchronization, and Work Overload

A Case of Inflammatory Bowel Disease

Speaker Introduction

Janina A. Krumbeck 1, Heather E. Rasmussen 2, Robert W. Hutkins 1*, Jennifer Clarke 1, Krista Shawron 3, Ali Keshavarzian 3* and Jens Walter 1,4,5,6*

Like every other part of the body gut bacteria can affect the thyroid and how it functions The information is preliminary Much of it is linking

FLARE-UPS: MANAGING STRESS AND ANXIETY

Early Supplementation of Human Milk Oligosaccharides Suppresses Spontaneous Autoimmune Diabetes in Non-obese Diabetic Mice Later in Life

Corporate Medical Policy Fecal Microbiota Transplantation

Slide 1 THYROID AND THE GUT. Slide 2. Slide 3 The Gut Affecting The Thyroid

The National Association of Crohn s and Colitis of Trinidad and Tobago CROHN S DISEASE AND ULCERATIVE COLITIS GENERAL PATIENT INFORMATION

CCFA. Crohns Disease vs UC: What is the best treatment for me? November

Complementary & Alternative Therapies in IBD

Ali Keshavarzian MD Rush University Medical Center

Transcription:

Ali Keshavarzian MD Rush University Medical Center, Chicago, IL

Ulcerative colitis Crohn s disease

Optimize Quality of Life Induce remission [treat flare up] Maintain remission [avoid flare up] Prevent & treat complications

% Patients Not Failing Trial 100 80 AZA 2.5 mg/kg/d (n=33) Placebo (n=30) 60 40 20 0 P=0.001 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Duration of Trial (months) * Remission induced by prednisolone tapered over 12 wk Candy S, et al. Gut. 1995;37:674.

Impact of environmental factors on IBD pathogenesis. Inflammatory bowel disease: the role of environmental factors Autoimmunity Reviews, Volume 3, Issue 5, 2004, 394-400

Impact of Sleep Disturbance in Inflammatory Bowel Disease. Journal of Gastroenterology and Hepatology, Volume 22, Issue 11, 2006

Impact of Sleep Disturbance in Inflammatory Bowel Disease. Journal of Gastroenterology and Hepatology, Volume 22, Issue 11, 2006

Sleep deprivation worsens inflammation and delays recovery in a mouse model of colitis Sleep Medicine, Volume 10, Issue 6, 2009

Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare? Expert Rev Clin Immunol. Volume 7, Issue 1, 2011

Rush University Ali Keshavarzian Christopher Forsyth Ece Mutlu Garth Swanson Maliha Shaikh Phillip Engen Northwestern University Fred Turek Martha Vitaterna Keith Summa Peng Jiang University of Illinois Stefan Green National Institute on Alcohol Abuse and Alcoholism AA020216: Brain-Gut Interactions in Alcohol-Induced Gut Leakiness AA023417: Role of Alcohol and Circadian Disruption in Inflammation and Colon Cancer AA019966: Circadian Desynchrony in Alcohol Induced Gut Leakiness

Monitoring Circadian Rhythms: Behavior

Preuss et al. Am. J. Physiol. 2008. 295: R2034-R2040.

Endogenous melatonin profiles in asymptomatic inflammatory bowel disease

Endogenous melatonin profiles in asymptomatic inflammatory bowel disease Scandinavian Journal of Gastroenterology, Volume 45, Issue 6, 2010

No Biologic Use Biologic Use 9:00 PM 12:00 AM 3:00 AM 3:14 9:00 PM 12:00 AM 3:00 AM 3:55 6:00 PM 6:00 AM 6:00 PM 6:00 AM 3:00 PM 12:00 PM 9:00 AM 3:00 PM 12:00 PM 9:00 AM = 2 observations ** **Watson Williams F test P < 0.05 Keshavarzian et al. DDW, 2016

Consistent Inconsistent 9:00 PM 12:00 AM 3:00 AM 18:44 19:21 9:00 PM 12:00 AM 3:00 AM 6:00 PM 6:00 AM 6:00 PM 6:00 AM 3:00 PM 12:00 PM 9:00 AM 3:00 PM 12:00 PM 9:00 AM = 9 observations = 7 observations SIBDQ 5.7 4.9 ** **Watson Williams F test P < 0.01 Keshavarzian et al. DDW, 2016

How does disrupted circadian rhythms worsen IBD?

Host Immune Response 1. Altered genetics making it ready for an immune system 2. Overactive T cells 3. Altered cytokine balance towards infalmmation 4. Lack of simple defense such as innate immune system Intestinal Milieu 1. Altered bacterial contents 2. Altered diet contents Intestinal Barrier - Primary defects - of mucous? - Defects in tissue repair

The Treatment-Naive Microbiome in New-Onset Crohn s Disease Cell Host & Microbe, Volume 15, Issue 3, 2014, 382-392

Changes in Microbiota Composition Increased intestinal permeability Promote pro-inflammatory immune response Promotes mucosal and systemic inflammation

Intestinal Barrier Function: Intestinal Permeability Administer: Sucralose, Sucrose, Lactulose, Mannitol Measure: Urinary sugar content

LBP (ng/ml) LBP (ng/ml) (A) 20000 16000 12000 8000 4000 Lipopolysaccharide Binding Protein at Baseline (B) 18000 16000 14000 12000 Day Shift Night Shift * * 0 Day Shift Night Shift 10000 0:00 06:00 12:00 18:00 0:00 Time Serum LBP in day shift and night shift workers (n=11). (A) Subjects with evidence of circadian rhythm disruption (i.e., night shift workers) have higher plasma LBP. (B) Cosinor analysis reveals significantly altered pattern of plasma LBP in night shift workers over a 24h period compared to day shift workers; day versus night shift workers mesor: 11109 v 13136, respectively (p=0.04). These results are indicative of increased endotoxemia and intestinal barrier dysfunction in subjects with circadian rhythm disruption.

Phillip Engen, BS Research Technician 2 Rush University Ankur Naqib PhD Student Research Assistant University of Illinois at Chicago Stefan J. Green, PhD Director DNA Services Facility University of Illinois at Chicago

Environmental CRD Alters the Intestinal Microbiota Under Challenging Conditions Family level Genus level Voigt et al, PLoS One, 2013

Average Abundance Day Night Day Night Day Night Day Night PCA PC2: 25.13% Variance? 6? 4? 2 0 2 4 18 16 14 12 10 8 6 4 2 0 Peptostreptococcaceae (A) (B) (C) (D) Turicibacteraceae Clostridiaceae Pseudomonadaceae day night (A) Peptostreptococcaceae (C) Clostridiaceae (B) Turicibacteraceae (D) Pseudomonadaceae P C A P C 2 : 2 5. 1 3 % v a r i a n c e Day Shift Workers Night Shift Workers?10?5 0 5 PCA PC1: 53.84% ar iance v PCA PC1: 53.8% Variance Fecal microbiota analysis in day shift and night shift workers (n=3). Genomic DNA was extracted from feces, and profiling was performed using 16S rrna gene amplicon sequencing. Analysis reveal that bacteria from the families Peptostreptococcaceae, Turicibacteraceae, and Clostridiaceae are more abundant in night shift workers compared to day shift workers. These data suggest that circadian rhythm disruption is associated with intestinal dysbiosis, particularly an increase in pro-inflammatory bacteria.

Butyrate / Total SCFA Production Ratio Butyrate to SCFA (A) 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0 p<0.05 Day Shift Worker Night Shift Worker * (B) 0.6 0.4 0.2 0.0 Day Shift Night Shift 0:00 06:00 12:00 18:00 0:00 Time Butyrate production as a ratio of total SCFA production (n=4). (A) Night shift workers with evidence of circadian rhythm disruption have significantly less plasma butyrate as a ratio compared to total SCFA production. (B) Cosinor analysis reveals significantly altered levels of butyrate to total SCFA production over a 24 h period; day versus night shift workers amplitude (p<0.05). These data suggest that the amount of butyrate produced as a proportion of total SCFA production is altered in subjects with circadian rhythm disruption which may contribute to altered intestinal barrier integrity and immune function. *

Plasma IL6 (pg/m) (A) 2.5 (B) 2.0 1.5 * 1.0 0.5 0.0 Day Shift Night Shift Day Shift Night Shift Plasma IL-6 in day shift and night shift workers (n=11). (A) Night shift workers have elevated levels of IL-6. (B) Cosine analysis demonstrates that night shift workers have significantly altered circadian pattern of IL-6; day versus night shift workers mesor: 1.73 v 2.20, respectively (p<0.02). These data suggest that circadian rhythm disruption promotes systemic inflammation.

What Factors Disrupt the Circadian Clock? Buttgereit et al, Nature Reviews Rheumatology 11: 349-356, 2015

Consequences of Circadian Disruption We propose that circadian rhythm disruption promotes inflammation via effects on the intestine Disrupted intestinal barrier integrity Intestinal microbiota dysbiosis Immune consequences Circadian misalignment could promote inflammation in patients with IBD and trigger IBD flare up Circadian misalignment [disrupted sleep/wake cycle; abnormal eating pattern] could worsen IBD course